Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peripheral inflammatory markers and clinical phenotypes reflecting the impact of diabetes on Parkinson's disease.

Journal of Parkinson's disease - 1 Dec 2025

Kwak In Hee, Ma Hyeo-Il, Kim Yun Joong, Noh Hye-Mi, Lee Jeongjae, Yu Je Kook, Kim Young Eun

Abstract excerpt

BackgroundType 2 diabetes mellitus (DM) can influence the phenotype and progression of Parkinson's disease (PD), as both conditions share inflammation as a common pathogenic mechanism.ObjectiveTo explore peripheral inflammatory indices that reflect the impact of DM on PD.MethodsWe analyzed 52 drug-naïve PD patients with DM and 182 without DM, along with age- and sex-matched healthy control (HC) with and without...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers
Share to Cholesterol, HDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Inflammation

Share to Parkinson Disease

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 40874566
DOI: 10.1177/1877718X251372392
PMCID: PMC13347537

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peripheral inflammatory markers and clinical phenotypes reflecting the impact of diabetes on Parkinson's disease.PMID 40874566Read ↗

Differential leukocyte count is associated with clinical phenotype in Parkinson's disease.Semantic proximity Read ↗

Low lymphocyte count is a risk factor for Parkinson’s diseaseSemantic proximity Read ↗

Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognitionSemantic proximity Read ↗

Inflammation-related gene polymorphisms associated with Parkinson’s disease: an updated meta-analysisSemantic proximity Read ↗

Circulating inflammatory proteins and risk of Parkinson’s disease and other neurodegenerative disorders: a two-sample Mendelian randomization studySemantic proximity Read ↗

Cellular phenotypes as inflammatory mediators in Parkinson's disease: Interventional targets and role of natural products.Semantic proximity Read ↗

Circulating inflammatory proteins and risk of Parkinson’s disease and other neurodegenerative disorders: a two-sample Mendelian randomization studySemantic proximity Read ↗

Plasma lipidome, circulating inflammatory proteins, and Parkinson’s disease: a Mendelian randomization studySemantic proximity Read ↗

Circulating Inflammatory miRNAs Associated with Parkinson’s Disease PathophysiologySemantic proximity Read ↗

Immune Profiling of Parkinson’s Disease Revealed Its Association With a Subset of Infiltrating Cells and Signature GenesSemantic proximity Read ↗

Peripheral Immune pattern in a genetic cohort of p.A53T alpha-synuclein Parkinson’s diseaseSemantic proximity Read ↗

Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.